Filing Details

Accession Number:
0001209191-19-059155
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-12-04 18:28:18
Reporting Period:
2019-12-02
Accepted Time:
2019-12-04 18:28:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1175505 Five Prime Therapeutics Inc. FPRX Pharmaceutical Preparations (2834) 260038620
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1273885 M Franklin Berger C/o Five Prime Therapeutics, Inc.
111 Oyster Point Boulevard
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-12-02 32,090 $3.92 52,890 No 4 S Direct
Common Stock Disposition 2019-12-03 47,890 $4.00 5,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.88 to $3.96, inclusive. The reporting person undertakes to provide to Five Prime Therapeutics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1 and 2 to this Form 4.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.97 to $4.03, inclusive.